IDEXX LABORATORIES INC (IDXX:NASDAQ)
$581.88 11.93 (2.0932%)
Analysed IDEXX LABORATORIES INC (IDXX:NASDAQ) News Sources
Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026?
15-04-2026
247wallst.com
Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls
15-04-2026
yahoo.com
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
15-04-2026
yahoo.com
Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now?
14-04-2026
yahoo.com
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
14-04-2026
yahoo.com
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
13-04-2026
yahoo.com
IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It?
13-04-2026
yahoo.com
IDEXX (IDXX) Launches Canine Cancer Detection Panel in UK
11-04-2026
yahoo.com
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
10-04-2026
yahoo.com
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
10-04-2026
yahoo.com
What is the current price of IDEXX LABORATORIES INC (IDXX:NASDAQ)?
The current price of IDEXX LABORATORIES INC (IDXX:NASDAQ) is $581.88.
IDEXX LABORATORIES INC (IDXX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IDEXX LABORATORIES INC (IDXX:NASDAQ) since the previous trading day is $11.93.
IDEXX LABORATORIES INC (IDXX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IDEXX LABORATORIES INC (IDXX:NASDAQ) since the previous trading day is 2.0932%.
What is the most recent average sentiment score for IDEXX LABORATORIES INC (IDXX:NASDAQ)?
The most recent average sentiment score for IDEXX LABORATORIES INC (IDXX:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for IDEXX LABORATORIES INC (IDXX:NASDAQ)?
The most recent sentiment for IDEXX LABORATORIES INC (IDXX:NASDAQ) is .
SEC-8K** Filing Available For IDEXX LABORATORIES INC (IDXX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.